16-10430802-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BP4_Strong
The NM_001393719.1(ATF7IP2):c.182C>T(p.Thr61Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001393719.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATF7IP2 | NM_001393719.1 | c.182C>T | p.Thr61Met | missense_variant | Exon 5 of 14 | ENST00000562102.6 | NP_001380648.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000393 AC: 1AN: 25468Hom.: 0 Cov.: 0
GnomAD3 exomes AF: 0.00000399 AC: 1AN: 250694Hom.: 0 AF XY: 0.00000738 AC XY: 1AN XY: 135530
GnomAD4 exome AF: 0.0000539 AC: 12AN: 222588Hom.: 0 Cov.: 0 AF XY: 0.0000451 AC XY: 5AN XY: 110752
GnomAD4 genome AF: 0.0000393 AC: 1AN: 25468Hom.: 0 Cov.: 0 AF XY: 0.00 AC XY: 0AN XY: 12248
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.182C>T (p.T61M) alteration is located in exon 2 (coding exon 1) of the ATF7IP2 gene. This alteration results from a C to T substitution at nucleotide position 182, causing the threonine (T) at amino acid position 61 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at